Neutral impactResults

AstraZeneca India Q2 FY27 results and new CFO

InvestyWise 1 hr ago·5 Nov 2026, 12:39 pm

This update concerns the Indian market. Read the full report at the source below.

Key takeaways

  • Category: Results.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at InvestyWise.

More Company news

More news
Life Insura Corp OF India

Life Insurance Corporation Of India — Investor Presentation

Life Insura Corp OF India₹408.00▲ 0.00%

NSE · 48 min ago

Inox India

INOX India Limited — Disclosure under SEBI Takeover Regulations

Inox India₹1,936.70▲ 0.00%

NSE · 48 min ago

Iris Regtech Solution

IRIS RegTech Solutions Limited — Press Release

Iris Regtech Solution₹217.87▲ 0.00%

NSE · 48 min ago

Sula Vineyards

Sula Vineyards Limited — Capacity addition (Sub-para 3-Para B)

Sula Vineyards₹134.85▲ 0.00%

NSE · 49 min ago

DC Infotech AND Comun

DC Infotech and Communication Limited — Outcome of Board Meeting

DC Infotech AND Comun₹332.25▲ 0.00%

NSE · 49 min ago

Chaman Metallics

Chaman Metallics Limited — Outcome of Board Meeting

Chaman Metallics₹117.50▲ 0.00%

NSE · 49 min ago

ICICILIFE NSE

ICICI Life Insurance Limited — Alteration Of Capital and Fund Raising-XBRL

ICICI Life Insurance₹423.05▲ 0.00%

NSE · 50 min ago

Venus Pipes & Tubes

Venus Pipes & Tubes Limited — Investor Presentation

Venus Pipes & Tubes₹1,843.00▲ 0.00%

NSE · 50 min ago

Classic Electrode (ind) L

Classic Electrodes (India) Limited — Outcome of Board Meeting

Classic Electrode (ind) L₹46.75▲ 0.00%

NSE · 50 min ago

Latest headlines

More news
Economy RBI

Master Directions on Cyber Resilience and Digital Payment Security Controls for non-bank Payment System Operators

RBI · 48 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.